Key facts
- This page summarizes Devin W. Smith's Form 4 filing for IO Biotech, Inc. (IOBT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2024, 18:52.
Devin W. Smith - 23 Dec 2024 Form 4 Insider Report for IO Biotech, Inc. (IOBT)
- Reporting relationship
- General Counsel
- Issuer ticker
- IOBT
- Reported as of
- 23 Dec 2024
- Net transaction value
- +$9,720
- SEC form
- 4
- Accepted by SEC
- 23 Dec 2024, 18:52:18 UTC
- Prior SEC filing
- 18 Mar 2024
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Burkavage, Attorney-in-Fact for Devin W. Smith
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Devin W. Smith filed Form 4 for IO Biotech, Inc. (IOBT) on 23 Dec 2024.
Change
- Previous filing in this sequence was filed on 18 Mar 2024.
- Current net transaction value: +$9,720.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IOBT
transaction
Common Stock
Purchase
- Transaction value
- $9,720
- Shares
- +12,000
- Change %
- +243%
- Price
- $0.8100
- Shares after
- 16,938
- Date
- 23 Dec 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.